The effects of the COVID-19 pandemic on patients with obsessive-compulsive disorder.

Obsessive-compulsive disorder anxiety severity fear of COVID-19 obsession with COVID-19 pandemic

Journal

International journal of psychiatry in clinical practice
ISSN: 1471-1788
Titre abrégé: Int J Psychiatry Clin Pract
Pays: England
ID NLM: 9709509

Informations de publication

Date de publication:
Mar 2023
Historique:
medline: 15 5 2023
pubmed: 7 6 2022
entrez: 6 6 2022
Statut: ppublish

Résumé

Little is known about the impact of the COVID-19 pandemic on obsessive-compulsive disorder (OCD). The main aim of this study was to investigate how the pandemic has affected OCD patients and the relationship between the clinical features and the fear and obsession with COVID-19. A total of 30 consecutive patients with OCD and 30 age-and sex-matched healthy controls were included in this cross-sectional study. Based on retrospective information provided by the patients, we evaluated changes in the severity of their OCD during the pandemic compared to the pre-pandemic period. We compared patients with OCD and healthy subjects using scores obtained from various scales. We found that symptom severity worsened in 60% of OCD patients during the pandemic compared to the pre-pandemic period, remained unchanged in 30%, and improved in 10%. The levels of obsession with COVID-19 were found to be higher in OCD patients than in healthy control subjects. The levels of fear of and obsession with COVID-19 both correlated with the anxiety levels of patients with OCD and healthy controls. Our results suggest that the levels of COVID-19 related fear and obsession are not linked to the severity of OCD, but to anxiety levels. Key pointsObsessive-compulsive symptom severity worsened in 60% of OCD patients in the pandemic.COVID-19 obsession levels were higher in OCD patients than healthy controls.COVID-19 fear levels did not differ between the OCD and healthy control groups.COVID-19 obsession levels were correlated with anxiety severity in OCD and healthy control groups.

Identifiants

pubmed: 35658743
doi: 10.1080/13651501.2022.2082984
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

35-41

Auteurs

Raşit Tükel (R)

Department of Psychiatry, Istanbul University Istanbul Faculty of Medicine, İstanbul, Turkey.

Oğuzhan Başaran (O)

Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Simge Ergün (S)

Department of Psychiatry, Istanbul University Istanbul Faculty of Medicine, İstanbul, Turkey.

Mourat Giousouf Chousein (MG)

Department of Psychiatry, Istanbul University Istanbul Faculty of Medicine, İstanbul, Turkey.

Mesut Keskin (M)

Department of Psychiatry, Istanbul University Istanbul Faculty of Medicine, İstanbul, Turkey.

Erhan Ertekin (E)

Department of Psychiatry, Istanbul University Istanbul Faculty of Medicine, İstanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH